若生智能
Drug Database
4-

4-factor prothrombin complex

✓ Approved

Intas Pharmaceuticals · F2 · 细胞治疗

什么是 4-factor prothrombin complex？

4-factor prothrombin complex 是一种细胞治疗，由Intas Pharmaceuticals研发。该药已获批，用于治疗相关适应症，给药途径：Injectable (Others)、Intravenous (IV)。

药物档案

公司Intas Pharmaceuticals
药物类别细胞治疗
分子靶点F2, F7, F9, F10
给药途径Injectable (Others), Intravenous (IV)
状态Approved
来源： ClinicalTrials.gov, Intas Pharmaceuticals

作用机制

分子靶点

4-factor prothrombin complex 作用于 4 个分子靶点：

F2coagulation factor II, thrombin (THPH1, PT)
F7coagulation factor VII (SPCA)
F9coagulation factor IX (P19, F9 p22)
F10coagulation factor X (FXA, FX)
需要更深入的分析？Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

4-factor prothrombin complex 针对 2 个适应症，涉及 1 个治疗领域。

治疗领域疾病/病症分期
Vascular disordersExtravasation blood✓ Approved
Vascular disordersHaemorrhage✓ Approved

相关研究文献

PubMedMenopause (New York, N.Y.)2026-08-04

Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study.

Qi Meiyuzhen M, Derby Carol A CA, Rader Daniel D, Janssen Imke I et al.

Limited research has assessed prospective associations of systemic inflammatory (GlycA) and immune (complement factor 3 [C3] and 4 [C4]) biomarkers with future cognition in midlife women, who potentially experience worsening inflammation around the menopause transition. We aim to assess the associations of midlife serum GlycA, C3, and C4 with future cognitive performance in women. Serum GlycA, C3, and C4 were repeatedly measured over 6.1 ± 3.9 years in 503 midlife women (1,234 observations) from the Study of Women's Health Across the Nation high-density lipoprotein ancillary study. Longitudinal measures of working memory, processing speed, and episodic memory, immediate and delayed recall, were administered 1.46 ± 0.95 years later. We applied joint models to examine the associations of baseline biomarkers and their changes since baseline with subsequent cognition. Higher levels of serum GlycA and complement factor 4 at baseline (50.17 ± 2.65 y) were significantly associated with worse working memory and better immediate recall, respectively, over the next decade. Higher baseline complement factor 4 and increases in C3 and C4 since baseline tended to associate with better future immediate and/or delayed recall. Higher baseline GlycA, rather than its changes since baseline, was associated with lower future working memory, whereas higher baseline complement factor 4 and increases in C3 and C4 since baseline appeared cognitively protective. Targeting inflammation amelioration and immunity improvement over the menopause transition may provide an open avenue to preserve future cognitive health.

PMID 42549661
阅读全文 →
PubMedArthroscopy techniques2026-08-04

Comprehensive Medial Knee Four-Arm Reconstruction to Address Complex Instability With Hamstring Autograft.

Malinowski Konrad K, Możdżeń Kamil K, Bawor-Mostowa Michalina M, Pękala Przemysław P et al.

Medial knee ligament injuries are increasingly recognized as complex, multiplanar lesions, resulting not only in simple medial instability but also anteromedial rotatory instability, anteromedial instability, posteromedial instability, posteromedial rotatory instability, and post-traumatic medial asymmetric hyperextension. The described technique extensively addresses all 6 above-described types of instability. It is based on 4 reconstruction arms with independent fixation. Two arms are created from a pedunculated semitendinosus autograft and 2 arms from a free gracilis autograft. The technique can reconstruct the medial ligamentous complex from the anteromedial aspect (anteromedial capsule/anterior oblique ligament/deep medial collateral ligament), through the superficial medial collateral ligament and posterior oblique ligament, up to the posteromedial capsule, in response to the pathology identified.

PMID 42549369
阅读全文 →
PubMedFrontiers in immunology2026-08-04

Explainable machine learning for predicting venous thromboembolism in septic shock patients.

Li Yuanyuan Y, Xin Qi Q, Lu Yizhao Y, Yu Xiaoyuan X et al.

Venous thromboembolism (VTE) frequently complicates septic shock, yet precise, individualized risk stratification tools remain scarce. This study aimed to develop and externally validate an explainable machine learning (ML) framework to predict VTE in this critically ill population. A retrospective cohort study was conducted including adult septic shock patients admitted between January 2020 and December 2025. The study population was partitioned into an internal development cohort (n=733) and an independent external validation cohort from a separate tertiary hospital (n=257, Xi'an No. 3 Hospital). We utilized the Boruta algorithm alongside recursive feature elimination to isolate optimal predictors. Six ML algorithms were trained and evaluated using metrics including the area under the receiver operating characteristic curve (AUC) and F1 score. Shapley Additive Explanations (SHAP) were integrated to establish model transparency. The VTE incidence within the development cohort was 17.74% (130/733). The feature selection pipeline distilled six robust predictors: fibrin degradation products (FDP), prothrombin time (PT), white blood cells (WBC), activated partial thromboplastin time (APTT), D-dimer, and C-reactive protein (CRP). Among the evaluated models, the Random Forest (RF) algorithm exhibited superior discriminative capacity and promising performance in an independent external validation cohort, achieving an AUC of 0.9718 and an F1 score of 0.7917 in the independent external validation cohort, with a sensitivity of 0.7037. SHAP analysis revealed that heightened thrombo-inflammatory markers combined with abbreviated coagulation intervals fundamentally drove VTE risk, offering personalized predictive insights via individual force plots. We successfully established a highly accurate and interpretable RF-based predictive model for VTE in septic shock patients. By leveraging six routine clinical biomarkers and SHAP-derived transparency, this tool bridges complex algorithmic forecasting with clinical intuition, providing a transparent risk assessment framework that may assist in risk stratification for thromboprophylaxis after prospective validation. Future implementation studies are needed to assess its real-world clinical utility and impact on patient outcomes.

PMID 42548631
阅读全文 →
PubMedQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2026-08-04

Examining the factor structure of health-related quality of life in spinal cord injury using confirmatory factor analysis and multidimensional scaling.

Tulsky David S DS, Boulton Aaron J AJ, Kisala Pamela A PA, Tyner Callie E CE et al.

Spinal cord injury (SCI) is a complex medical condition and managing the multiple, co-occurring symptoms and functional and social limitations that follow SCI is a challenging task for clinical care providers. Understanding how the various post-SCI symptoms and limitations are interrelated or cluster together can inform patient care and improve clinical workflows. The purpose of this study was to determine the factor structure of the SCI-QOL measurement system and associated symptom clusters that affect health-related quality of life (HRQOL) in individuals with SCI. Participants were individuals with SCI living in the community (> 1 year after injury) recruited from 8 rehabilitation hospitals in the U.S. who completed 18 Spinal Cord Injury - Quality of Life (SCI-QOL) outcomes measures representing domains of physical, medical, social, and emotional health. Two dimension-reduction techniques, confirmatory factor analysis and multidimensional scaling, were used to analyze the data. Factor analysis results suggest 7 common factors underlying the measures: Physical Symptoms, Physical Function, Negative Affect, Positive Affect, Social Health, Independence, and Pain Interference. The psychosocial factors of Negative Affect, Positive Affect, and Social Health were highly interrelated. Large correlations were also observed between Physical Function and Independence, and between Physical and Social Health. All other interrelations were small to moderate. Results from the multidimensional scaling analysis were largely consistent with those from the factor analysis. Study results will help inform the development of composite scores and symptom profiles in SCI, which will help researchers and clinicians better understand and manage symptoms following SCI.

PMID 42547660
阅读全文 →
PubMedDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections2026-08-04

Taxonomic Delineation of Fusarium weifangense within the F. incarnatum-equiseti Species Complex.

Gagkaeva T Yu TY, Orina A S AS, Gavrilova O P OP

Modern delineation of the Fusarium species using genetic data faces challenges no less complex than those previously encountered, when species descriptions were based exclusively on morphological characteristics. In present study, the taxonomic status of five fungal strains belonging to the F. incarnatum-equiseti species complex, which is a highly heterogeneous group of Fusarium, was clarified. The strains were isolated from wild and cultivated grasses and maintained in the fungal collections for 13-18 years under the epithet F. semitectum (syn. F. incarnatum). More precise identification of these strains as F. weifangense was achieved by combining phylogenetic analysis of fragments of the translation elongation factor 1α gene, the gene encoding RNA polymerase subunit II analyses, and calmodulin gene with morphological description and pathogenicity evaluation. The results of a comparative analysis of the phenotypic characteristics of the strains with those previously reported for this species, which are largely inconsistent. That differences in morphological description may be due to internal polymorphism of taxon, as well as differences in methodological approaches used by different research groups. The analyzed strains caused weak necrosis of wheat leaves inoculated under laboratory conditions, which indicates that F. weifangense is a non-pathogenic fungus. However, the previously demonstrated ability of the F. weifangense strains to produce zearalenone and diacetoxyscirpenol makes it necessary to clarify area and adaptive properties of this fungus.

PMID 42550420
阅读全文 →
PubMedMetabolic engineering2026-08-04

Systematic Metabolic Engineering of Escherichia coli for High-Level Production of trans-4-Hydroxy-L-proline.

Wang Kai K, Tian Shu-Ping SP, Wan Shuo S, Chen Xiu-Lai XL et al.

As a high-value-added amino acid derivative, trans-4-hydroxy-L-proline (T-4-Hyp) faces key bottlenecks in its microbial production from glucose, including insufficient precursor supply and an imbalance between cell growth and product biosynthesis. In this study, we successfully constructed an engineered Escherichia coli strain QF-27 for efficient T-4-Hyp production. First, the L-proline (L-Pro) biosynthetic pathway was enhanced by overexpressing the feedback-resistant γ-glutamyl kinase, glutamate-γ-semialdehyde dehydrogenase, and pyrroline-5-carboxylate reductase, and by knocking out the L-proline dehydrogenase. The resulting strain QF-9 produced 15.75 ± 0.56 g/L of L-Pro. Subsequently, the expression level of proline-4-hydroxylase from Dactylosporangium sp. RH1 was optimized in strain QF-9, and the resulting strain QF-14 produced 5.32 ± 0.26 g/L of T-4-Hyp. To address the insufficient supply of α-ketoglutarate (α-KG), a multi-modular synergistic strategy (i.e., blocking byproduct pathways, enhancing α-KG flux, and relieving global transcriptional repression) increased T-4-Hyp production to 11.02 ± 0.27 g/L. Moreover, a dynamic switch combining PrpsT promoter and DAS+4 degradation tag was designed to repress expression and promote degradation of the α-ketoglutarate dehydrogenase complex during the stationary phase, thereby balancing cell growth and T-4-Hyp production. Consequently, T-4-Hyp production reached 14.37 ± 0.46 g/L, and residual L-Pro fell to 0.38 ± 0.17 g/L. In fed-batch fermentation, the final strain QF-27 produced 105.72 ± 0.84 g/L of T-4-Hyp with productivity of 2.20 g/L/h and carbon yield of 0.364 g/g glucose. To our knowledge, this is the best performance reported for T-4-Hyp production by microbial fermentation, and the first study to enhance it via systematic modification of central carbon metabolism.

PMID 42547008
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多4-factor prothrombin complex